Atlas Trials

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Clinical trial NCT04782388 · COMPLETED

Trial details

NCT number
NCT04782388
Sponsor
UCB Biopharma SRL
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Study Participants
Start date
2021-03-04
Primary completion
2021-04-26
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.